clozapine guidance - Sussex Partnership NHS Foundation Trust
... treatment. Community initiation must be conducted with appropriate support for the patient consisting of information and essential monitoring. Clozapine initiated in the community can provide effective treatment and allow patients to be treated in the environment most appropriate for them. The most ...
... treatment. Community initiation must be conducted with appropriate support for the patient consisting of information and essential monitoring. Clozapine initiated in the community can provide effective treatment and allow patients to be treated in the environment most appropriate for them. The most ...
Diette GB, McCormack MC, Hansel NN, Breysse PN, Matsui EC. Environmental issues in managing asthma. Respir Care. 2008;53(5): p.602-15; discussion 616-7. Review.
... Management of asthma requires attention to environmental exposures both indoors and outdoors. Americans spend most of their time indoors, where they have a greater ability to modify their environment. The indoor environment contains both pollutants (eg, particulate matter, nitrogen dioxide, secondha ...
... Management of asthma requires attention to environmental exposures both indoors and outdoors. Americans spend most of their time indoors, where they have a greater ability to modify their environment. The indoor environment contains both pollutants (eg, particulate matter, nitrogen dioxide, secondha ...
Suggestion from clinicians
... goal achievement in patients with hypercholesterolemia. Trial results indicate that rosuvastatin 10 to 40 mg has greater efficacy than atorvastatin 10 to 80 mg, simvastatin 10 to 80 mg, and pravastatin 10 to 40 mg for achievement of ATP III LDL-C and non-HDL-C goals, European LDL-C goals, and Canadi ...
... goal achievement in patients with hypercholesterolemia. Trial results indicate that rosuvastatin 10 to 40 mg has greater efficacy than atorvastatin 10 to 80 mg, simvastatin 10 to 80 mg, and pravastatin 10 to 40 mg for achievement of ATP III LDL-C and non-HDL-C goals, European LDL-C goals, and Canadi ...
KIT FOR THE PREPARATION OF TECHNETIUM Tc 99m
... • detecting coronary artery disease by localizing myocardial ischemia (reversible defects) and infarction (non-reversible defects) (1) • evaluating myocardial function and developing information for use in patient management decisions (1) -------------- DOSAGE AND ADMINISTRATION-------------• For My ...
... • detecting coronary artery disease by localizing myocardial ischemia (reversible defects) and infarction (non-reversible defects) (1) • evaluating myocardial function and developing information for use in patient management decisions (1) -------------- DOSAGE AND ADMINISTRATION-------------• For My ...
KIT FOR THE PREPARATION OF TECHNETIUM Tc 99m
... • detecting coronary artery disease by localizing myocardial ischemia (reversible defects) and infarction (non-reversible defects) (1) • evaluating myocardial function and developing information for use in patient management decisions (1) -------------- DOSAGE AND ADMINISTRATION-------------• For My ...
... • detecting coronary artery disease by localizing myocardial ischemia (reversible defects) and infarction (non-reversible defects) (1) • evaluating myocardial function and developing information for use in patient management decisions (1) -------------- DOSAGE AND ADMINISTRATION-------------• For My ...
Report - Institute for Clinical and Economic Review
... Approximately one-third of American adults have cardiovascular disease (CVD), making it the most common cause of death in the United States.3 The American Heart Association (AHA) defines cardiovascular disease as anyone with a history of myocardial infarction (MI), stroke, angina, congestive heart f ...
... Approximately one-third of American adults have cardiovascular disease (CVD), making it the most common cause of death in the United States.3 The American Heart Association (AHA) defines cardiovascular disease as anyone with a history of myocardial infarction (MI), stroke, angina, congestive heart f ...
RISPERDAL
... 3 mg per day. Although efficacy has been demonstrated in studies of adolescent patients with schizophrenia at doses between 1 mg to 6 mg per day, no additional benefit was observed above 3 mg per day, and higher doses were associated with more adverse events. Doses higher than 6 mg per day have no ...
... 3 mg per day. Although efficacy has been demonstrated in studies of adolescent patients with schizophrenia at doses between 1 mg to 6 mg per day, no additional benefit was observed above 3 mg per day, and higher doses were associated with more adverse events. Doses higher than 6 mg per day have no ...
2011 clinical practice guide for diabetic retinopathy for latin america
... of colleagues dedicated to community health programs from five countries (Brazil, Chile, Colombia, Ecuador, and Mexico) and with advice from the IAPB, which provided information about the successful experiences of other countries, such as Scotland, in the early detection of DR. Key r ...
... of colleagues dedicated to community health programs from five countries (Brazil, Chile, Colombia, Ecuador, and Mexico) and with advice from the IAPB, which provided information about the successful experiences of other countries, such as Scotland, in the early detection of DR. Key r ...
revised clinical study protocol 1
... pharmacokinetic (PK) data to progress the compound whilst exposing as few patients as possible to AZD9773. The study will consist of 2 successive cohorts, with a total of 20 patients planned (10 patients per cohort) from approximately 10 Japanese sites. For each cohort, initially 10 patients will be ...
... pharmacokinetic (PK) data to progress the compound whilst exposing as few patients as possible to AZD9773. The study will consist of 2 successive cohorts, with a total of 20 patients planned (10 patients per cohort) from approximately 10 Japanese sites. For each cohort, initially 10 patients will be ...
2014 Appendicitis - AZ Priority Care
... Risk factors for appendicitis include male gender, Caucasian ethnicity, and presentation in the summer months. In addition, young age is a risk factor for appendicitis, with 69% of cases occurring in persons less than 30 years old and the highest incidence occurring in 10- to 14-year-old males and 1 ...
... Risk factors for appendicitis include male gender, Caucasian ethnicity, and presentation in the summer months. In addition, young age is a risk factor for appendicitis, with 69% of cases occurring in persons less than 30 years old and the highest incidence occurring in 10- to 14-year-old males and 1 ...
BayeraspirinHCP.com
... 9. Amsterdam EA, Wenger NK, Brindis RG, et al. 2014 AHA/ACC guideline for the management of patients with non–ST-elevation acute coronary syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014;64(24):e139-e228. ...
... 9. Amsterdam EA, Wenger NK, Brindis RG, et al. 2014 AHA/ACC guideline for the management of patients with non–ST-elevation acute coronary syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014;64(24):e139-e228. ...
A Use of Metformin in the Setting of ficiency Mild-to-Moderate Renal Insuf
... were considered to be appropriate at 1.4 mg/dL in women and 1.5 mg/dL in men. This was based on the calculated ability to remove 3 g of metformin (an amount slightly beyond the maximum daily U.S. dose) at steady-state levels within 24–48 h. In fact, the ability to comfortably remove the drug extends ...
... were considered to be appropriate at 1.4 mg/dL in women and 1.5 mg/dL in men. This was based on the calculated ability to remove 3 g of metformin (an amount slightly beyond the maximum daily U.S. dose) at steady-state levels within 24–48 h. In fact, the ability to comfortably remove the drug extends ...
product monograph serc
... evaluated, therefore its use in this population is not recommended. Geriatrics (> 65 years of age) Limited data from clinical studies suggest that a dosage adjustment is unlikely to be required in this patient group. In general, however, the risk of adverse reactions to any drug may be greater in el ...
... evaluated, therefore its use in this population is not recommended. Geriatrics (> 65 years of age) Limited data from clinical studies suggest that a dosage adjustment is unlikely to be required in this patient group. In general, however, the risk of adverse reactions to any drug may be greater in el ...
Accidental Hypothermia - Calgary Emergency Medicine
... ACLS / AHA guidelines and algorithm, Calgary protocol treatment modalities including some “new” ones hypothermia zingers ...
... ACLS / AHA guidelines and algorithm, Calgary protocol treatment modalities including some “new” ones hypothermia zingers ...
Practical Use of the Pessary
... effect can be minimized with the use of an acidic vaginal gel such as Trimo-San, which also helps to relieve minor irritation and itching. Some physicians recommend that patients douche with dilute vinegar or hydrogen peroxide for relief.4,10 Postmenopausal women with thin vaginal mucosa are more su ...
... effect can be minimized with the use of an acidic vaginal gel such as Trimo-San, which also helps to relieve minor irritation and itching. Some physicians recommend that patients douche with dilute vinegar or hydrogen peroxide for relief.4,10 Postmenopausal women with thin vaginal mucosa are more su ...
AusPAR: Prednisone
... According to the Product Information document (PI), the initial daily dose is 10 mg and this may be titrated down in steps of 1 mg. In some cases short-term higher treatments of 12, 15 or 20 mg are required and thus the maximum daily dose is 20 mg. It follows from this and the tablets strengths bein ...
... According to the Product Information document (PI), the initial daily dose is 10 mg and this may be titrated down in steps of 1 mg. In some cases short-term higher treatments of 12, 15 or 20 mg are required and thus the maximum daily dose is 20 mg. It follows from this and the tablets strengths bein ...
HIGHLIGHTS OF PRESCRIBING INFORMATION These
... 1 Indications and Usage ABILIFY MAINTENA (aripiprazole) is indicated for the treatment of schizophrenia [see Clinical Studies (14)]. 2 Dosage and Administration 2.1 Dosage Overview for the Treatment of Schizophrenia ABILIFY MAINTENA is only to be administered by intramuscular injection by a healt ...
... 1 Indications and Usage ABILIFY MAINTENA (aripiprazole) is indicated for the treatment of schizophrenia [see Clinical Studies (14)]. 2 Dosage and Administration 2.1 Dosage Overview for the Treatment of Schizophrenia ABILIFY MAINTENA is only to be administered by intramuscular injection by a healt ...
Patient Care Facility Accreditation - American Board for Certification
... The American Board for Certification in Orthotics, Prosthetics and Pedorthics, Inc. (ABC) is an independent, nonprofit, standardsetting organization for the accreditation of orthotic, prosthetic, pedorthic and mastectomy patient care practices as well as the certification of practitioners in these d ...
... The American Board for Certification in Orthotics, Prosthetics and Pedorthics, Inc. (ABC) is an independent, nonprofit, standardsetting organization for the accreditation of orthotic, prosthetic, pedorthic and mastectomy patient care practices as well as the certification of practitioners in these d ...
State Operations Manual Appendix A - Survey Protocol,
... The modules for PPS-exempt units (psychiatric and rehabilitation), psychiatric hospitals, rehabilitation hospitals and swing-bed hospitals are attached to this document. The survey team is expected to use all the modules that apply to the hospital being surveyed. For example, if the hospital has swi ...
... The modules for PPS-exempt units (psychiatric and rehabilitation), psychiatric hospitals, rehabilitation hospitals and swing-bed hospitals are attached to this document. The survey team is expected to use all the modules that apply to the hospital being surveyed. For example, if the hospital has swi ...
Australasian treatment guidelines for the management of pancreatic exocrine insufficiency
... Pancreatic exocrine insufficiency Pancreatic exocrine insufficiency occurs when amounts of enzymes secreted into the duodenum in response to a meal are not sufficient to maintain normal digestive processes. There are three main reasons why sufficient pancreatic enzymes may not be available:1 1. Ins ...
... Pancreatic exocrine insufficiency Pancreatic exocrine insufficiency occurs when amounts of enzymes secreted into the duodenum in response to a meal are not sufficient to maintain normal digestive processes. There are three main reasons why sufficient pancreatic enzymes may not be available:1 1. Ins ...
Phenytoin: A Guide to Therapeutic Drug Monitoring
... complicating phenytoin dosing include a narrow therapeutic window, high degree of protein binding, and nonlinear pharmacokinetics. However, serum drug levels should only be taken when there is a clear indication to guide patient management. Scenarios where monitoring levels may be clinically useful ...
... complicating phenytoin dosing include a narrow therapeutic window, high degree of protein binding, and nonlinear pharmacokinetics. However, serum drug levels should only be taken when there is a clear indication to guide patient management. Scenarios where monitoring levels may be clinically useful ...
Full Prescribing Information
... either peptic ulcer disease or gastrointestinal bleeding. Patients treated with NAMZARIC should be monitored closely for symptoms of active or occult gastrointestinal bleeding, especially those at increased risk for developing ulcers, e.g., those with a history of ulcer disease or those receiving co ...
... either peptic ulcer disease or gastrointestinal bleeding. Patients treated with NAMZARIC should be monitored closely for symptoms of active or occult gastrointestinal bleeding, especially those at increased risk for developing ulcers, e.g., those with a history of ulcer disease or those receiving co ...
American Society of Clinical Oncology Guideline for Antiemetics in
... and other databases, with evaluation of the evidence by 23 oncology professionals in clinical medicine, medical oncology, radiation oncology, oncology nursing, statistics, pharmacy, medical policy and decision making, and pharmacology.11 The consensus statements and treatment guidelines coming from ...
... and other databases, with evaluation of the evidence by 23 oncology professionals in clinical medicine, medical oncology, radiation oncology, oncology nursing, statistics, pharmacy, medical policy and decision making, and pharmacology.11 The consensus statements and treatment guidelines coming from ...